Heterozygous Familial Hypercholesterolemia (heFH) Therapeutics – Pipeline Analysis 2018, Clinical Trials & Results
Heterozygous familial hypercholesterolemia (HeFH) is an inherited genetic disorder that affects the body’s ability to control cholesterol. It is characterized by very high LDL (low [read full press release…]